Aethlon Medical (AEMD) vs Femasys (FEMY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Femasys is the larger company by market cap ($10.7 million vs $8.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AEMD | FEMY |
|---|---|---|
| Share price | $5.46 | $1.24 |
| Market cap | $8.78M | $10.73M |
| 1-day change | +12.81% | 0.00% |
| YTD return | — | -89.24% |
| 1-year return | — | -93.26% |
| 5-year return | — | -98.63% |
| EPS (TTM) | $-16.22 | $-1.79 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $2.29M |
| Revenue growth (YoY) | — | +40.77% |
| Net income (latest FY) | $-7.15M | $-18.63M |
| Gross margin | — | 61.96% |
| Operating margin | — | -766.95% |
| Net margin | — | -812.27% |
| 52-week high | $24.75 | $20.80 |
| 52-week low | $1.41 | $1.07 |
| Distance from 52-week high | -77.94% | -94.04% |
| Analyst consensus | none | none |
| Avg. price target upside | +142.67% | +1055.65% |
| Average volume | 2.56M | 110.75K |
| Shares outstanding | 1.61M | 8.66M |
| Employees | 9 | 51 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aethlon Medical
AEMD stock →Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states.
Health Care · Medical/Dental Instruments · 9 employees
About Femasys
FEMY stock →Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation.
Health Care · Medical/Dental Instruments · 51 employees
AEMD vs FEMY FAQ
Which is bigger, Aethlon Medical or Femasys?
Femasys (FEMY) is larger, with a market capitalization of $10.73M compared with $8.78M for Aethlon Medical (AEMD).
Are Aethlon Medical and Femasys in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.